Proposal for NVS - Pneumo support: Yemen
The government is applying for approx. US$ 23 million over two years from GAVI to support the introduction of pneumococcal vaccine into its routine immunisation schedule. Co-financing amounts to approx. US$ 730,000. The application is based on the disease burden and WHO recommendations and is seen as essential to reduce child mortality and morbidity in Yemen. The country's cMYP has been updated accordingly. Yemen is requesting the vaccine in its currently available PCV-7 composition.